NanoString Technologies has pulled in another $20 million to capitalize on its genetic analysis instrument for researchers, and to pursue the lofty goal of creating a workhorse diagnostic tool that enables more personalized medicines. The Seattle-based company is announcing today it has raised $20 million in its Series D venture financing, which includes new investors … Continue reading “NanoString Grabs $20M From GE, Former Genzyme CEO to Pursue Molecular Diagnostics”
Category: Boston
XL Hybrids, With New D.I.Y. Approach, Gears Up to Go Beyond Vehicle Retrofits
If you want something done right, the old saying goes, do it yourself. That’s exactly what XL Hybrids, a Boston-based transportation tech startup, is up to these days. Despite a thin layer of gloom that pervades much of the cleantech industry, XL Hybrids is advancing in its quest to make commercial vans and trucks greener … Continue reading “XL Hybrids, With New D.I.Y. Approach, Gears Up to Go Beyond Vehicle Retrofits”
Groupon: The IPO With More Sizzle, and Money, Than the Entire Biotech IPO Class of 2011
Groupon raked in so much cash through its initial public offering last week that it could buy the entire class of life sciences companies that have gone public in 2011. For those of you who aren’t following the Groupon melodrama, the Chicago-based online daily deals site raised $700 million last week in its IPO after … Continue reading “Groupon: The IPO With More Sizzle, and Money, Than the Entire Biotech IPO Class of 2011”
Best Buy Co. Acquires mindSHIFT Technologies for $167,000,000
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=0c88145f-c27b-44ec-9205-6c3922dd43ec&Preview=1 Date 11/7/2011 Company Name mindSHIFT Technologies Mailing Address 309 Waverley Oaks Rd. Waltham, MA 02452 Company Description mindSHIFT is a leading Managed Services Provider (MSP) offering both managed services and professional services to small- and medium-sized businesses. Website http://www.mindshift.com Transaction Type M&A Transaction Amount $167,000,000 Transaction Round Proceeds Purposes M&A Terms … Continue reading “Best Buy Co. Acquires mindSHIFT Technologies for $167,000,000”
AMAG Shares Zoom on CEO Departure and Re-Org Plans
Today, during its third-quarter earnings announcement, Lexington, MA-based AMAG Pharmaceuticals (NASDAQ: [[ticker:AMAG]]) announced the departure of its CEO, Brian Pereira, and a restructuring plan designed to decrease its operating expenses. Wall Street applauded, pushing the embattled company’s shares up 18 percent to $16.21.The news came just a couple of weeks after shareholders voted down Amag’s plan to … Continue reading “AMAG Shares Zoom on CEO Departure and Re-Org Plans”
This Week’s Xconomy Report on WGBH: Zuckerberg’s Change of Heart, IDing Adults Online, Vocal Cord Repair, and Verastem IPO
Xconomy and the folks at WGBH (Bob Seay, to be precise) are at it again: bringing you the latest and greatest in news from Boston’s innovation community. The Xconomy Report airs every Friday morning at 7:49am on 89.7 FM. To find out about the project that both The Who’s Roger Daltrey and actress Julie Andrews … Continue reading “This Week’s Xconomy Report on WGBH: Zuckerberg’s Change of Heart, IDing Adults Online, Vocal Cord Repair, and Verastem IPO”
Top 3 Takeaways From Our Twitter Chat With Appature’s Kabir Shahani
In advance of his appearance at Xconomy’s “6×6: Six Cities, Six Big Tech Ideas” conference on Dec. 1 in Boston, I did a live tweet chat with Kabir Shahani, the co-founder and CEO of Seattle-based Appature, yesterday. Thanks to all who tuned in and sent us their thoughts; we had a great audience. Appature is … Continue reading “Top 3 Takeaways From Our Twitter Chat With Appature’s Kabir Shahani”
Mobile App Search is So Bad AltaVista Could Have Done It. Chomp Is Biting Off the Problem
There are roughly 500,000 iPhone and iPad apps in Apple’s iTunes App Store, and almost that many smartphone and tablet apps in Google’s Android Market. That gives mobile consumers lots of choices, but it has created an untenable situation for mobile developers. Unless you get lucky and your app vaults onto the top-5 or top-10 … Continue reading “Mobile App Search is So Bad AltaVista Could Have Done It. Chomp Is Biting Off the Problem”
Come Get Coffee With Xconomy at Our Tuesday Meetup. And GI Alumni, Bring Your Swag
We spend most of our time at Xconomy banging out stories about innovation, and putting together our big conferences like “The Genetics Institute Impact” coming up Dec. 14. But sometimes we love nothing more than just meeting at a local establishment to shoot the breeze with readers over a cup of coffee. So that’s what … Continue reading “Come Get Coffee With Xconomy at Our Tuesday Meetup. And GI Alumni, Bring Your Swag”
Xconomy Meetup With Luke Timmerman & Erin Kutz
Join Xconomy’s national biotech editor, Luke Timmerman, and Xconomy Boston associate editor Erin Kutz, for a free and informal “Xconomy Meetup.” There will be no program, just some time to meet and chat with the editors. This gathering will be from 10 am to 11:30 am on Nov. 8 at Voltage Coffee & Art, 295 … Continue reading “Xconomy Meetup With Luke Timmerman & Erin Kutz”
Langer Nabs Cash From Rock Stars, Verastem Seeks $50M IPO, Alnylam Snags RNAi Collab, & More Boston-Area Life Sciences News
We’ve seen life sciences headlines from a mix of established drugmakers and universities in New England this week. —Waltham, MA-based Repligen is picking up a unit of the Danish industrial-biotech products maker Novozymes A/S for about $22.7 million in cash. Repligen (NASDAQ: [[ticker:RGEN]]) could also pay another roughly $5.6 million to the unit, Novozymes Biopharma … Continue reading “Langer Nabs Cash From Rock Stars, Verastem Seeks $50M IPO, Alnylam Snags RNAi Collab, & More Boston-Area Life Sciences News”
Xconomists of the Week: Tom Maniatis and Marc Tessier-Lavigne Lead the Charge on the New York Genome Center
Today marked the official launch of the New York Genome Center, a collaboration among 11 top academic institutions that’s designed to accelerate genomic research. The initiative—supported by the City of New York and private and public institutions—is being guided by two of our Xconomists: Rockefeller University’s Marc Tessier-Lavigne, who will serve on the center’s board … Continue reading “Xconomists of the Week: Tom Maniatis and Marc Tessier-Lavigne Lead the Charge on the New York Genome Center”
Founder Dialogues VI
This edition of Founder Dialogues features Wayfair (formerly CSN Stores) founders Niraj Shah and Steven Conine. Sign up here for the chat moderated by Founder Collective’s Eric Paley.
Deals Inked for Basho, Innocentive
Boston’s big data cluster recently got some attention at the MassTLC Innovation UnConference, and Basho Technologies, one of the companies in the space, followed up this week with a funding announcement. Check out that news and another IT financing below. —Basho, a Cambridge, MA-based developer of data storage and management software, announced it had pulled … Continue reading “Deals Inked for Basho, Innocentive”
Infographic: College or Incubator for Startup Founders?
[Updated 11/4 at 2:30 pm] Not everyone can be a Gates, Allen, Jobs, or Zuckerberg—founders who dropped out of college and went on to change the technology industry by starting landmark companies. But there are more options available for budding entrepreneurs these days, most notably the explosion of incubators, accelerators, and other startup nurseries that … Continue reading “Infographic: College or Incubator for Startup Founders?”
Verastem, the 15-Month Old Christoph Westphal Venture in Cancer Stem Cells, Seeks IPO
Cambridge, MA-based Verastem has big names and big science on its side, which a lot of startups have, but now it’s doing something quite unconventional for a company that’s just 15 months old—it’s trying to go public. Verastem, the company led by former Sirtris Pharmaceuticals CEO Christoph Westphal and founded on science from MIT luminaries … Continue reading “Verastem, the 15-Month Old Christoph Westphal Venture in Cancer Stem Cells, Seeks IPO”
The Accidental Entrepreneur: David Skok of Matrix Partners Talks Marketing Lessons, VMware Killers, and VC Missteps
His last name means “forest” in Norwegian. Which is appropriate, because this guy sees the forest for the trees. David Skok of Matrix Partners is one of the most talked-about venture capitalists in town, among young entrepreneurs and experienced ones alike. He is best known for his investments in JBoss, the open source middleware company … Continue reading “The Accidental Entrepreneur: David Skok of Matrix Partners Talks Marketing Lessons, VMware Killers, and VC Missteps”
Tru.ly’s Tech Takes a Crack at Verifying Online Identity for Liquor Websites, Gaming, Online Dating and More
Take a former D.C. lobbyist who’s now the owner of a chain of liquor stores, mix him with some security software engineers and you get Cambridge, MA-based Tru.ly. The startup’s software enables users to verify that they are who in fact they say they are online. Web users can apply for credentials via Tru.ly, with … Continue reading “Tru.ly’s Tech Takes a Crack at Verifying Online Identity for Liquor Websites, Gaming, Online Dating and More”
InnoCentive Obtains $1,701,321 New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=3e42f714-72ee-4619-86e4-985c2adcd08a&Preview=1 Date 11/3/2011 Company Name InnoCentive Mailing Address 610 Lincoln St. Waltham, MA 02451 Company Description InnoCentive is an exciting new web-based community matching top scientists to relevant R&D challenges facing leading companies from around the globe. Website http://www.innocentive.com Transaction Type Venture Equity Transaction Amount $1,701,321 Transaction Round Undisclosed Proceeds Purposes Undisclosed … Continue reading “InnoCentive Obtains $1,701,321 New Financing Round”
Sand 9 Garners $3,095,262 New Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=dd16d165-b1f5-4002-ac52-a121deece6bc&Preview=1 Date 11/3/2011 Company Name Sand 9 Mailing Address One Kendall Square Cambridge, MA 02139 Company Description Sand 9, Inc. is a venture funded startup company, dedicated to the design of Radio Frequency components that will dramatically improve the performance and increase the capabilities of wireless devices. Our disruptive proprietary technology offers … Continue reading “Sand 9 Garners $3,095,262 New Financing”
Tracelytics Receives $600,000 Seed Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=b2d819e4-2c01-4e05-96ad-380d58769458&Preview=1 Date 11/3/2011 Company Name Tracelytics Mailing Address 171 Chestnut Street 2nd Floor Providence, RI 02903 Company Description Tracelytics is the SaaS-based application performance tool that understands scalable web architectures. Erase the boundaries between applications, layers, and machines; start tracing. Website http://www.tracelytics.com Transaction Type Venture Equity Transaction Amount $600,000 Transaction Round Seed … Continue reading “Tracelytics Receives $600,000 Seed Financing”
OnForce Obtains New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=2ee571ad-7c63-415a-8f7b-f52a8f093131&Preview=1 Date 11/3/2011 Company Name OnForce Mailing Address 10 Maguire Road Bldg. 2 Lexington, MA 02421 Company Description OnForce is the industry’s first and most advanced on-demand marketplace on the web for on-site technology services in the U.S. OnForce enables large and small enterprises to compete more effectively in today’s global digital … Continue reading “OnForce Obtains New Funding Round”
Patience, Honesty, and The Strings of Free Money: Five Financing Themes from the Seventh Annual Conference on Clean Energy
The relationship between venture capitalists and cleantech startups sure seems pretty lukewarm these days, at least from what I saw yesterday at the seventh Conference on Clean Energy in Boston. The lunchtime “VC” panel on cleantech funding 2.0 actually focused more on why venture capital isn’t necessarily the best move for financing transformative energy technologies, and … Continue reading “Patience, Honesty, and The Strings of Free Money: Five Financing Themes from the Seventh Annual Conference on Clean Energy”
Seeding Entrepreneurship: How to Build a Venture-Finance Ecosystem
[Editor’s note: Cross-posted from The Economist, 11/2/11] New York Mayor-entrepreneur Michael Bloomberg, not known for shyness, recently proclaimed New York City as America’s new entrepreneurship capital, roaring past Boston in venture capital and soon to leave Silicon Valley in the dust as the “go to” destination for entrepreneurs. Indeed, the world media are awash with … Continue reading “Seeding Entrepreneurship: How to Build a Venture-Finance Ecosystem”
Bob Langer’s Latest Project: Fix Damaged Vocal Cords for Rock Stars, Cancer Patients
Bob Langer has probably been called a rock star a time or two, but now the famous MIT scientist’s work is being supported by actual rock stars. Langer, an Xconomist, is working on a project to create a vibrating gel which is thought to have potential to rejuvenate damaged vocal cords, according to a feature … Continue reading “Bob Langer’s Latest Project: Fix Damaged Vocal Cords for Rock Stars, Cancer Patients”
Join Us Thursday for a Twitter Chat with CEO Kabir Shahani of Marketing Tech Startup Appature
Twitter has already sucked away 20 percent of your life. What’s another 30 minutes? If you don’t know Kabir Shahani or his startup, Appature, here is your chance. I will be hosting a live Twitter chat with him tomorrow (Thursday, Nov. 3). This open chat will start at 2 pm Eastern / 11 am Pacific … Continue reading “Join Us Thursday for a Twitter Chat with CEO Kabir Shahani of Marketing Tech Startup Appature”
Repligen Buys Novozymes Unit, World Energy Acquires GSE Consulting, Alnylam Partners With GSK, & More Boston-Area Deals News
The last week’s deals headlines have been shared among New England cleantech, IT, and life sciences companies. —Russian Federation fund Rusnano pumped money into two Bay State biotechs: Cambridge, MA-based BIND Biosciences and Watertown, MA-based Selecta Biosciences. Each startup got $25 million from Rusnano, a fund focused on nanotechnology investments, as well as $22.25 million … Continue reading “Repligen Buys Novozymes Unit, World Energy Acquires GSE Consulting, Alnylam Partners With GSK, & More Boston-Area Deals News”
MX Orthopedics Garners $1,000,000 Seed Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=b9b56fd2-6e27-40f1-9890-6bcc00220489&Preview=1 Date 11/2/2011 Company Name MX Orthopedics Mailing Address 12 Suburban Park Drive Billerica, MA 01821 Company Description Mx Orthopedics has created a next generation hip implant device that it says minimizes future movement of the device. Website http://www.mxortho.com Transaction Type Venture Equity Transaction Amount $1,000,000 Transaction Round Seed Proceeds Purposes Proceeds … Continue reading “MX Orthopedics Garners $1,000,000 Seed Financing Round”
Powerhouse Dynamics Lands $3,000,000 Series A Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=b409a0af-65ba-419b-86e5-53a304a23b79&Preview=1 Date 11/2/2011 Company Name Powerhouse Dynamics Mailing Address One Bridge Street Newton, MA 02458 Company Description Powerhouse Dynamics provides new, cost-effective energy management solutions for small commercial operations. Website http://www.powerhousedynamics.com Transaction Type Venture Equity Transaction Amount $3,000,000 Transaction Round Series A Proceeds Purposes The funding will fuel its expansion into the … Continue reading “Powerhouse Dynamics Lands $3,000,000 Series A Funding Round”
Steel in Their Eyes—Why VCs should be Startup CEOs
A man who carries a cat by the tail learns something he can learn in no other way. —Mark Twain Venture capitalists who are serious about turning their firms into more than one-fund wonders may want to have their associates actually start and run a company for a year. Running a company is distinctly different … Continue reading “Steel in Their Eyes—Why VCs should be Startup CEOs”
Web Innovators Group 32
Check out the November edition of WebInno, a demo field for the newest Web and mobile tech from area startups. Registration is free for entrepreneurs, students, and other “startup peeps,” so sign up here.
Alnylam and Glaxo Partner on RNAi for Vaccine Production
Cambridge, MA-based Alnylam Pharmaceuticals (NASDAQ: [[ticker:ALNY]]) announced today that it has formed a collaboration deal with GlaxoSmithKline (NYSE: [[ticker:GSK]]) centered around an RNAi technology Alnylam developed to enhance vaccine production. The technology, called VaxiRNA, uses molecules called “small interfering RNAs” (siRNAs) to silent specific genes that limit the efficient growth of viruses in vaccine manufacturing … Continue reading “Alnylam and Glaxo Partner on RNAi for Vaccine Production”
World Energy Buys GSE for $8.6M, Gains Foothold in Texas
Some interesting news in cleantech today. Worcester, MA-based World Energy Solutions (NASDAQ: [[ticker:XWES]]) said it has acquired GSE Consulting, an energy management and procurement firm based in Dallas, TX, for $8.6 million plus a potential earn-out. World Energy said it will bring on more than 20 GSE employees across three offices in Texas. The move … Continue reading “World Energy Buys GSE for $8.6M, Gains Foothold in Texas”
Modo Labs Closes $4M Series A, Looks to Take Education and Enterprise Apps by Storm
Score one for open source startups. Modo Labs, a Cambridge, MA-based mobile software company, is announcing today it has closed a $4 million Series A round from Storm Ventures and New Magellan Ventures. The round includes $2 million that the startup raised last year; the new money ($2 million) comes from Silicon Valley-based Storm, led … Continue reading “Modo Labs Closes $4M Series A, Looks to Take Education and Enterprise Apps by Storm”
Biopharma Industry Meetings Could Use Some Fresh Voices
One or more notices of upcoming biopharma industry conferences arrive in my email every day. I give their agendas a quick glance before deleting them, as they’re seldom in areas I focus on. The vast majority of presenters are plucked from the ranks of top-tier Big Pharma; there’s a seminar from Pfizer, a speaker from … Continue reading “Biopharma Industry Meetings Could Use Some Fresh Voices”
Top 10 Highlights From UnConference: Boston’s Big Data Cluster, Content Vs. Commerce & More
This year’s MassTLC Innovation UnConference, in Boston on Friday, was as overwhelming—and inspiring—as ever. Apart from the “secrets of scaling startups” session, which I recapped in a separate story, there was a lot going on. Far too much for any one person to take in. There were sessions on picking the right startup accelerator; building … Continue reading “Top 10 Highlights From UnConference: Boston’s Big Data Cluster, Content Vs. Commerce & More”
PathoGenetiX Secures $7,500,000 Series B Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=308a5e21-30d2-4b06-b57b-de34540d70fb&Preview=1 Date 11/1/2011 Company Name PathoGenetiX Mailing Address 12 Gill Street Woburn, MA 01801 Company Description PathoGenetiX has pioneered commercial applications of single molecule DNA, RNA and protein analysis. The company’s innovative technologies address high value unmet needs in bio-security, human diagnostics, and food and drug contaminant monitoring. Addressable segments of these … Continue reading “PathoGenetiX Secures $7,500,000 Series B Financing”
Modo Labs Receives $4,000,000 Series A Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=c5f74bb3-e2c7-4869-9450-49dfaf7dcfb1&Preview=1 Date 11/1/2011 Company Name Modo Labs Mailing Address 100 Cambridgepark Dr Cambridge, MA 02140 Company Description We began as a band of colleagues at MIT, united by a shared belief that mobile technologies will improve the world in unprecedented ways. We’ve assembled a team of experts in mobile technology and user … Continue reading “Modo Labs Receives $4,000,000 Series A Financing”
The Economy in 17 Syllables, All of Them Gloomy
For the third quarter of 2011, the Ewing Marion Kauffman Foundation leavened its otherwise morose quarterly survey of economics bloggers (PDF) with something new: a haiku contest. The 63 academics, entrepreneurs, investors, and journalists who participated in the survey, including myself, were asked to describe the state of the economy in the form of a haiku, … Continue reading “The Economy in 17 Syllables, All of Them Gloomy”
Morgenthaler Ventures, ATV To Merge Life Sciences Teams, Form New Fund
Morgenthaler Ventures and Advanced Technology Ventures, a couple of longstanding and diversified venture firms, have decided to split off their life sciences investment teams and merge them into a new independent biotech fund, Xconomy has learned. The news was reported earlier today by Fortune’s Dan Primack. The new life sciences fund, which doesn’t have a … Continue reading “Morgenthaler Ventures, ATV To Merge Life Sciences Teams, Form New Fund”
Woes Mount for Local Energy Companies Beacon Power and American Superconductor
Things aren’t looking so sunny for Tyngsboro, MA-based Beacon Power (NASDAQ: [[ticker:BCON]]) and Devens, MA-based American Superconductor (NASDAQ: [[ticker:AMSC]]), a couple of prominent public companies in the cleantech sector. —Beacon Power, a flywheel energy storage company, filed documents seeking Ch. 11 bankruptcy protection. The move has shone some negative light on the U.S. Department of … Continue reading “Woes Mount for Local Energy Companies Beacon Power and American Superconductor”
Facebook Should Have Stayed in Boston, and Other Quotable Moments from Y Combinator’s Startup School
For startup people, the 714 seats inside Dinkelspiel Auditorium at Stanford University were the hottest ones in the country on Saturday. That was the day of Startup School, the invitation-only event produced by Stanford’s student entrepreneur group BASES and Mountain View, CA-based venture incubator Y Combinator. For the seventh year in a row, a cast … Continue reading “Facebook Should Have Stayed in Boston, and Other Quotable Moments from Y Combinator’s Startup School”
Personalized Medicine Conference
This conference, put on by Partners HealthCare and Harvard Medical School and Business School, will look at the impact personalized medicine innovations will have on healthcare systems. Panels and sessions will cover new healthcare models, the business aspect of personalized medicine, public policy, and the impact of the $1,000 genome, among other subjects. Register here.
Scaling Up Startups: Takeaways from Gemvara, Kayak, LogMeIn, Wayfair, and More at MassTLC UnConference
Get a bunch of prominent Boston-area founders and CEOs in a room together, and ask them provocative questions. It’s a tried and true recipe for a good discussion, and that’s exactly what we got at the end of the day on Friday at MassTLC’s 2011 unConference at Hynes Convention Center in Boston. The topic was … Continue reading “Scaling Up Startups: Takeaways from Gemvara, Kayak, LogMeIn, Wayfair, and More at MassTLC UnConference”
TEDxNewEngland
This inaugural TEDxNewEngland event features speakers in arts, media, academia, and business. Check this out for more information on the independently organized TED event.
The Cancer Drug Dark Ages Are Coming to an End
Only a couple stories in the past decade have given advocates of personalized cancer medicines much to brag about. There was Genentech’s Herceptin for a form of breast cancer in 1998, and Novartis’ Gleevec for chronic myeloid leukemia in 2001. But just a few short weeks ago, in August, we saw a flurry of FDA … Continue reading “The Cancer Drug Dark Ages Are Coming to an End”
Platform-as-a-Service Startup Mendix Pockets $13M Series A
[Updated 10/31/11 10:00 am. See below.] Mendix, a Boston-based developer of software platforms enabling business customers to develop, deploy, and manage applications, has announced its Series A round of funding. The $13 million financing was led by growth equity firm Prime Ventures, with participation by Mendix seed investor HENQ Invest. [Paragraph and headline updated because originally … Continue reading “Platform-as-a-Service Startup Mendix Pockets $13M Series A”
Today’s Xconomy Report: Biogen Idec Meets Goals in Clinical Trial, iRobot Layoffs, $1M Awarded by MassChallenge, and Bay State Venture Capital Earnings
Today’s news: Weston, MA-based Biogen Idec, the largest maker of injectable treatments for multiple sclerosis, met its goals in a second clinical trial for an oral pill to treat the disease. The pill reduced flare-ups by 44 percent when taken twice per day, and by 51 percent if taken three times a day. Bedford, MA-based … Continue reading “Today’s Xconomy Report: Biogen Idec Meets Goals in Clinical Trial, iRobot Layoffs, $1M Awarded by MassChallenge, and Bay State Venture Capital Earnings”
Report: Gilt Picking Up Troubled Daily Deals Site BuyWithMe
[Updated 10/28/11 2:00 p.m. See below.] According to BetaBeat, fashion site Gilt Groupe is in the final stages of acquiring its New York neighbor BuyWithMe, a daily deals site that made six acquisitions this year and expanded to Seattle—but then started showing signs of distress. Just last week, reports emerged that BuyWithMe, which started in Boston, … Continue reading “Report: Gilt Picking Up Troubled Daily Deals Site BuyWithMe”
Repligen Buys Novozymes Unit, Expanding Product Base and Manufacturing Capacity
After the stock market closed last night, Waltham, MA-based Repligen (NASDAQ: [[ticker:RGEN]]) announced that it will buy a Swedish unit of Novozymes A/S, the Danish maker of industrial-biotech products, for 17 million euros, or about $22.7 million cash, plus 5 million euros ($5.6 million) in potential milestone payments. The unit, called Novozymes Biopharma Sweden, makes … Continue reading “Repligen Buys Novozymes Unit, Expanding Product Base and Manufacturing Capacity”